PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+6.54%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.11B
AUM Growth
+$3.11B
(+8.3%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
2.96%
Top 10 Holdings %
Top 10 Hldgs %
37.14%
Holding
93
New
12
Increased
19
Reduced
13
Closed
9
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$76.3M |
| 2 |
Centene
CNC
|
$37.3M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$36.7M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$23.6M |
| 5 |
Guardant Health
GH
|
$21.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$41.5M |
| 2 |
AstraZeneca
AZN
|
$36M |
| 3 |
Insulet
PODD
|
$30.9M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$29.1M |
| 5 |
Gilead Sciences
GILD
|
$28.1M |
Sector Composition
| 1 | Healthcare | 94.1% |
| 2 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$19.4B
| $45.8M | 1.44% | 132,272 +30,238 | +30% | +$10.5M |
|
27
Tenet Healthcare
THC
$16.3B
| $44.7M | 1.4% | 667,073 +103,629 | +18% | +$6.94M |
|
|
MYOV
28
DELISTED
Myovant Sciences Ltd.
MYOV
| $43.5M | 1.36% | 1,912,188 -142,740 | -7% | -$3.25M |
|
29
Waters Corp
WAT
$18B
| $40.7M | 1.27% | 117,634 +4,545 | +4% | +$1.57M |
|
30
Baxter International
BAX
$12.7B
| $36.9M | 1.16% | 458,667 +191 | +0% | +$15.4K |
|
31
Syndax Pharmaceuticals
SNDX
$1.41B
| $36.8M | 1.15% | 2,144,881 +660,654 | +45% | +$11.3M |
|
32
Penumbra
PEN
$10.6B
| $36.7M | 1.15% | 133,759 +59,408 | +80% | +$16.3M |
|
|
AERI
33
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $34.9M | 1.1% | 2,182,684 +115,000 | +6% | +$1.84M |
|
34
Heron Therapeutics
HRTX
$207M
| $34.1M | 1.07% | 2,199,057 +100,479 | +5% | +$1.56M |
|
35
Cytokinetics
CYTK
$4.23B
| $33.4M | 1.05% | 1,687,012 +150,639 | +10% | +$2.98M |
|
36
Novavax
NVAX
$1.21B
| $31.7M | 0.99% | 149,104 -51,641 | -26% | -$11M |
|
37
Icon
ICLR
$13.8B
| $29.8M | 0.93% | 144,227 +78,364 | +119% | +$16.2M |
|
38
Dynavax Technologies
DVAX
$1.19B
| $29.5M | 0.92% | 2,990,770 | – | – |
|
39
Intellia Therapeutics
NTLA
$1.22B
| $28.9M | 0.9% | 178,222 -105,879 | -37% | -$17.1M |
|
40
Butterfly Network
BFLY
$405M
| $26.5M | 0.83% | 1,828,311 | – | – |
|
|
CANO
41
DELISTED
Cano Health, Inc.
CANO
| $25.3M | 0.79% | 2,094,279 -432,315 | -17% | -$5.23M |
|
|
ARNA
42
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $23.6M | 0.74% | +345,523 | New | +$23.6M |
|
|
JNCE
43
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $22.2M | 0.7% | 3,262,833 | – | – |
|
|
KRTX
44
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $22M | 0.69% | 193,386 +14,540 | +8% | +$1.66M |
|
45
Molina Healthcare
MOH
$9.8B
| $17.7M | 0.56% | 70,088 | – | – |
|
46
Zai Lab
ZLAB
$3.68B
| $17.6M | 0.55% | 99,375 | – | – |
|
47
Thermo Fisher Scientific
TMO
$186B
| $17.6M | 0.55% | +34,829 | New | +$17.6M |
|
48
Labcorp
LH
$23.1B
| $17.6M | 0.55% | +63,640 | New | +$17.6M |
|
|
CNST
49
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $15.9M | 0.5% | 469,664 | – | – |
|
50
Allogene Therapeutics
ALLO
$251M
| $15.8M | 0.5% | 606,800 +16,422 | +3% | +$428K |
|